Truvada
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- undated
- Valid until
- still holds
- Published
- 2018-02-27
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-10 · its source page states the value and the date
- Confidence
- 0.80
Sources
“Truvada (emtricitabine/TDF) is an oral formulation dosed once a day as part of combination therapy to treat HIV infection in adults. It is a fixed-dose combination of our antiretroviral medications, TDF and emtricitabine.”— what the page says, read 2026-11-10
- https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm
- https://www.wikidata.org/wiki/Q663596
Cite this claim
Plain text
AsOf. "Gilead Sciences produces: Truvada", undated. Claim clm_1AC53307215A, https://asof.is/claim/clm_1AC53307215A, accessed 2026-11-11. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm.
APA
AsOf. (n.d.). Gilead Sciences produces: Truvada (undated) [Record clm_1AC53307215A]. Retrieved November 11, 2026, from https://asof.is/claim/clm_1AC53307215A (source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm)
BibTeX
@misc{asof_clm_1AC53307215A,
author = {AsOf},
title = {Gilead Sciences produces: Truvada},
howpublished = {\url{https://asof.is/claim/clm_1AC53307215A}},
note = {Claim clm\_1AC53307215A, undated; source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm},
urldate = {2026-11-11}
}On the record
/claim/clm_1AC53307215A.md/v1/claims/clm_1AC53307215Asubmit a correction